LORVOTUZUMAB MERTANSINE
UNII 0IVD6ASY0W

Substance Identification & Data

This profile provides standardized clinical and technical data for Lorvotuzumab Mertansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0IVD6ASY0W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1008106-64-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0IVD6ASY0W

CAS Registry Number

1008106-64-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LORVOTUZUMAB MERTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C38714

National Cancer Institute reference terminology for clinical and research data.

INN ID

9299

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-83

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lorvotuzumab Mertansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LORVOTUZUMAB MERTANSINE

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD56 ANTIGEN) (HUMAN-MOUSE MONOCLONAL HUN901 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUN901 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(3-((3-CARBOXY-1-METHYLPROPYL)DITHIO)-1-OXOPROPYL)-N2'-DEACETYLMAYTANSINE

LORVOTUZUMAB MERTANSINE [INN]

LORVOTUZUMAB MERTANSINE [USAN]

LORVOTUZUMAB MERTANSINE [WHO-DD]

MAYTANSINOID DM1-CONJUGATED HUMANIZED MONOCLONAL ANTIBODY N901